| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423117A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423106A1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 06/02/2004 | EP1423099A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423098A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1265623B1 Pharmaceutical compositions including alginates |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | CN1501941A Chemical compounds |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501809A Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 06/02/2004 | CN1500521A Keep-in-mouth tablet for oral ulcer and preparation method |
| 06/02/2004 | CN1500514A Oral colon-positioned triperygium wilfordii composition and its use |
| 06/02/2004 | CN1500497A Preparation method of compound soft capsule of traditional Chinese medicine and use |
| 06/02/2004 | CN1500496A Preparation method of compound dispersed tablet of traditional Chinese medicine and use |
| 06/02/2004 | CN1500495A Use of dictyoptera grease in healthcare food and medicine , its preparation method |
| 06/02/2004 | CN1500488A Oral colon-positioned medicine composition for curing bacillary dysentery |
| 06/02/2004 | CN1500481A Medicine for toothache |
| 06/02/2004 | CN1500408A Edible oil palm fibre powder ,food containing the same and production method |
| 06/02/2004 | CN1152039C Benzo (b) thiepine-1, 1-dioxide derivatives, producing method thereof, combination containing the same and uses thereof |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide |
| 06/02/2004 | CN1152006C Biphenyl derivatives |
| 06/02/2004 | CN1151815C Capsule for treating hepatic disease |
| 06/02/2004 | CN1151812C Medicinal preparation for curing infantile anorexia and food preference |
| 06/02/2004 | CN1151808C Snuff inhalant for treating cardiovascular and cerebrovascular disease |
| 06/02/2004 | CN1151806C Capsule for curing cholecystitis,gall bladder, pancreatitis,icterohepatitis |
| 06/02/2004 | CN1151802C Capsule for invigorating function of brain and its preparing process |
| 06/02/2004 | CN1151798C 活性双歧杆菌胶囊 Active Bifidobacterium Capsules |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743795 Inhibitors for hepatitis b and acquired immune deficiency syndrome (aids) because they interfere with removal of rna strand from rna-dna hybrid formed during the reverse transcription of viral rna to dna |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | CA2293336C Methods of using isomer enriched conjugated linoleic acid compositions |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043455A1 Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain |
| 05/27/2004 | WO2004043367A2 Fused heterocyclic compounds and use thereof |
| 05/27/2004 | WO2004016583A8 Substituted glycine derivatives for use as medicaments |
| 05/27/2004 | WO2004001655A8 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 05/27/2004 | WO2003095637B1 Combination of a growth factor and a protease enzyme |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003086412B1 Polyphosphonate derivatives for toothpaste compositions |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003070245B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102615 Method for isolating and purifying a protein and resulting protein |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102484 Prodrugs of proton pump inhibitors |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102478 Alzheimer's and Parkinson's disease; antiinflamamtory agents; antiallergens; vision defects |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102414 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040101956 For drug screening kits; therapy/prophylaxis; genetic engineering |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101593 Preventives or remedies for tumor of human papillomaviral disease |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101565 Mehtod to obtain microparticles containing a h+ k+ atp-ase inhibitor |
| 05/27/2004 | US20040101562 Enzyme encapsulated in hydrophilic low melting polymer; bioavailability |
| 05/27/2004 | US20040101558 Drug with enteric coating; oral administering |
| 05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
| 05/27/2004 | CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/26/2004 | EP1422524A1 Screening method |
| 05/26/2004 | EP1422292A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421949A1 Hepatitis b virus proliferation inhibitor |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421944A1 Antacid and laxative tablets |